Business Club, April 11th News Affairs Department My stake betting appstake sports betting appof stake online sports bettingthe Department of Market Order of the Ministry of Commerce, Wang Shengli Director Wang Shengli revealed to reporters on April 9，The "Outline of the National Development Plan for the National Pharmaceutical Distribution Industry" that has been brewing for one year will be announced by May。
According to the "Outline" that the "Outline" previously learned by this newspaper, the review draft，"Support large pharmaceutical circulation enterprises through acquisition、merge、Host、Stock participation and holding and holding a variety of ways to grow bigger and stronger，Realize scale、intensive and international operations "and other" such as "intensive and international operation" have been clearly written，The merger and integration of the pharmaceutical circulation industry will be further accelerated。
For the development goals before 2015，"Outline" My stake betting appstake sports betting appMy stake betting appproposed quantification indicators，"The national large-scale pharmaceutical business group with an annual sales of 1-3 sales of more than 100 billion yuan，20 regional pharmaceutical circulation enterprises with annual sales of more than 10 billion yuan; the annual sales of the top 100 enterprises of drug wholesale accounted for more than 85%of the total drug wholesale，Pharmaceutical retail chain companies account for more than 70%of the total sales of drug retail enterprises; chain pharmacies account for two -thirds of the proportion of all retail stores。"
At present，Chinese Medicine Holdings、Shanghai Pharmaceutical and Kyushu Tong scale ranked in the top three nationwide，Farly leading other companies。Its China Medicine Holding parent company Sinopharm Group will not be difficult to sell over 100 billion yuan this year。
Statistics from the China Medical My stake betting appstake online sports bettingBusiness Association show，2009，my country's total annual sales of pharmaceutical business enterprises in China 396.4 billion yuan，accounting for 60.74%of the total commercial sales of the country。Where，8 companies with an annual sales scale of more than 10 billion yuan，Sinopharm Group、Shanghai Medical Distribution Company、Kyushu Tong、Nanjing Medicine、Guangzhou Medicine、Anhui Huayuan Pharmaceutical Co., Ltd.、Bei Medical Co., Ltd. and Chongqing Pharmaceutical shares。(Author: Wang Weijia)
